HELP — Cybin Inc. Common Stock

HELP closed at $10.19 (-2.95%) on Oct 23, 2026. Float: 50.1M shares. Latest SEC filing: 3 on Oct 26, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for HELP in the TickerWise workspace.

Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: CA
• Exchange: NASDAQ
• Employees: 50
• Website: http://www.cybin.com

Latest SEC filings for HELP

• 2026-10-263
• 2026-10-233
• 2026-10-233
• 2026-10-233
• 2026-10-233
• 2026-10-216-K
• 2026-10-156-K
• 2026-10-086-K
• 2026-10-056-K
• 2026-10-016-K

Related companies

• VRTX — Vertex Pharmaceuticals Incorporated
• MRNA — Moderna, Inc.
• REGN — Regeneron Pharmaceuticals, Inc.
• ARGX — argenx SE
• ALNY — Alnylam Pharmaceuticals, Inc.
• INSM — Insmed Incorporated
• RVMD — Revolution Medicines, Inc.
• UTHR — United Therapeutics Corporation

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.